Literature DB >> 29786104

Correlation between the expression of IL‑18 and deep venous thrombosis.

Guangdi Li1, Rudan Zhou2, Xueling Zhao2, Riguang Liu1, Chuan Ye1.   

Abstract

The present study aimed to investigate the effect of the expression of interleukin (IL)‑18 and related markers on deep venous thrombosis (DVT) to examine their correlation. Sprague‑Dawley rats of different models were established and were randomly assigned into three groups. The expression of IL‑18, nuclear factor (NF)‑κB and von Willebrand factor (vWF) were detected in blood samples. The inferior vena cava (IVC) was ligated to establish the DVT model. Rat IL‑18 overexpression and inhibition vectors were constructed. The expression levels of IL‑18 and related markers in the venous wall were compared between the model group and the control group using reverse transcription‑quantitative polymerase chain reaction and western blot analyses. Following the culture of human umbilical vein endothelial cells (HUVECs), IL‑18 was added to the cells, following which the growth of the HUVECs, and changes in vWF and other endothelial functional markers were analyzed. The IVC model demonstrated complete thrombosis at 8 h and stable thrombosis at 24 h. At 24 h following model establishment, the expression levels of IL‑18, NF‑κB and vWF were high in the blood samples with the occurrence and development of thrombosis (P<0.05). The weight, length and weight/length ratio of thrombi in each model group showed significant differences from those in the control group (P<0.05) with the overexpression of IL‑18, and the expression levels of NF‑κB and vWF in venous tissues were altered with abnormal expression levels of IL‑18. IL‑18 damaged HUVECs and significantly increased viability in early‑stage apoptosis, promoted the upregulation of vWF and P‑selectin, and reduced tissue plasminogen activator. IL‑18 and the related markers were closely associated with the occurrence and development of DVT.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29786104      PMCID: PMC6192771          DOI: 10.3892/ijmm.2018.3682

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


GUANGDI LI, RUDAN ZHOU, XUELING ZHAO, RIGUANG LIU, CHUAN YE Int J Mol Med 42: 883‑896, 2018; DOI: 10.3892/ijmm.2018.3843 In the above paper, the authors realize that an error inadvertently appeared in the funding section on p. 895. Where "This study was supported by the National Natural Science Foundation of China Science Fund Project (grant no. 30960389 and 8176010097)" was written, the application number 8176010097 was featured incorrectly: This should have been written as grant no. 81760030. Therefore, this sentence in the funding section should have read as follows: "This study was supported by the National Natural Science Foundation of China Science Fund Project (grant nos. 30960389 and 81760030)". The authors regret this error was not noticed prior to the publication, and apologize to their funding body and to the readership of the Journal for any inconvenience caused.
  24 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Crosstalk in NF-κB signaling pathways.

Authors:  Andrea Oeckinghaus; Matthew S Hayden; Sankar Ghosh
Journal:  Nat Immunol       Date:  2011-07-19       Impact factor: 25.606

3.  A novel role for interleukin-18 in adhesion molecule induction through NF kappa B and phosphatidylinositol (PI) 3-kinase-dependent signal transduction pathways.

Authors:  J C Morel; C C Park; J M Woods; A E Koch
Journal:  J Biol Chem       Date:  2001-07-27       Impact factor: 5.157

Review 4.  NF-κB, inflammation, and metabolic disease.

Authors:  Rebecca G Baker; Matthew S Hayden; Sankar Ghosh
Journal:  Cell Metab       Date:  2011-01-05       Impact factor: 27.287

5.  Deep vein thrombosis resolution is modulated by monocyte CXCR2-mediated activity in a mouse model.

Authors:  Peter K Henke; Andrea Varga; Sumit De; C Barry Deatrick; Jonathon Eliason; Douglas A Arenberg; Pasu Sukheepod; Porama Thanaporn; Steven L Kunkel; Gilbert R Upchurch; Thomas W Wakefield
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-04-22       Impact factor: 8.311

6.  P-selectin and leukocyte microparticles are associated with venous thrombogenesis.

Authors:  Daniel D Myers; Angela E Hawley; Diana M Farris; Shirley K Wrobleski; Porama Thanaporn; Robert G Schaub; Denisa D Wagner; Anjali Kumar; Thomas W Wakefield
Journal:  J Vasc Surg       Date:  2003-11       Impact factor: 4.268

7.  Laminin activates NF-kappaB in Schwann cells to enhance neurite outgrowth.

Authors:  Stephanie J Armstrong; Mikael Wiberg; Giorgio Terenghi; Paul J Kingham
Journal:  Neurosci Lett       Date:  2008-05-01       Impact factor: 3.046

8.  Activation of intrinsic and extrinsic proapoptotic signaling pathways in interleukin-18-mediated human cardiac endothelial cell death.

Authors:  Bysani Chandrasekar; Kirankumar Vemula; Rama Mohan Surabhi; Min Li-Weber; Laurie B Owen-Schaub; Liselotte E Jensen; Srinivas Mummidi
Journal:  J Biol Chem       Date:  2004-02-11       Impact factor: 5.157

9.  von Willebrand factor in plasma: a novel risk factor for recurrent myocardial infarction and death.

Authors:  J H Jansson; T K Nilsson; O Johnson
Journal:  Br Heart J       Date:  1991-11

10.  NF-kappaB mediated enhancement of potassium currents by the chemokine CXCL1/growth related oncogene in small diameter rat sensory neurons.

Authors:  Rui-Hua Yang; Judith A Strong; Jun-Ming Zhang
Journal:  Mol Pain       Date:  2009-05-28       Impact factor: 3.395

View more
  7 in total

1.  Formononetin regulates endothelial nitric oxide synthase to protect vascular endothelium in deep vein thrombosis rats.

Authors:  Zhongxiao Zhou; Haimeng Zhou; Xin Zou; Xiaowei Wang; Mengjun Yan
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.298

2.  Identification of thrombomodulin as a dynamic monitoring biomarker for deep venous thrombosis evolution.

Authors:  Xi Cheng; Baolan Sun; Shiyi Liu; Dandan Li; Xiaoqing Yang; Yuquan Zhang
Journal:  Exp Ther Med       Date:  2020-12-14       Impact factor: 2.447

Review 3.  Inflammation in Cerebral Venous Thrombosis.

Authors:  Jiayue Ding; Baoying Song; Xiran Xie; Xaingyu Li; Zhiying Chen; Zhongao Wang; Liqun Pan; Duo Lan; Ran Meng
Journal:  Front Immunol       Date:  2022-04-04       Impact factor: 8.786

Review 4.  Inflammation and Severe Cerebral Venous Thrombosis.

Authors:  Shuyuan Hu; Hangil Lee; Haiping Zhao; Yuchuan Ding; Jiangang Duan
Journal:  Front Neurol       Date:  2022-07-22       Impact factor: 4.086

5.  Evaluation of Blood Coagulation Parameters and ADMA, NO, IL-6, and IL-18 Serum Levels in Patients with Neovascular AMD before, during, and after the Initial Loading Phase of Intravitreal Aflibercept.

Authors:  Michał Wiciński; Małgorzata Seredyka-Burduk; Sławomir Liberski; Daria Marczak; Magdalena Pol; Bartosz Malinowski; Katarzyna Pawlak-Osińska; Bartlomiej J Kaluzny
Journal:  Life (Basel)       Date:  2021-05-14

6.  Research Progress of Oxidative Stress and MicroRNAs in the Prevention of Catheter-Related Thrombus Under Resistance Exercise.

Authors:  Cui Wen; Yanping Ying; Fu Yu; Jianpeng Zhou
Journal:  Clin Appl Thromb Hemost       Date:  2020 Jan-Dec       Impact factor: 2.389

7.  Identifying of Anti-Thrombin Active Components From Curcumae Rhizoma by Affinity-Ultrafiltration Coupled With UPLC-Q-Exactive Orbitrap/MS.

Authors:  Zhenwei Lan; Ying Zhang; Yue Sun; Lvhong Wang; Yuting Huang; Hui Cao; Shumei Wang; Jiang Meng
Journal:  Front Pharmacol       Date:  2021-12-10       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.